Ocular Therapeutix Inc (OCUL)
7.81
0.00 (0.00%)
USD |
NASDAQ |
Apr 16, 16:00
7.81
0.00 (0.00%)
After-Hours: 19:38
Ocular Therapeutix Price to Book Value: 12.74 for April 16, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 15, 2024 | 12.75 |
| April 12, 2024 | 13.03 |
| April 11, 2024 | 13.50 |
| April 10, 2024 | 12.90 |
| April 09, 2024 | 13.32 |
| April 08, 2024 | 13.03 |
| April 05, 2024 | 13.76 |
| April 04, 2024 | 13.81 |
| April 03, 2024 | 13.78 |
| April 02, 2024 | 13.83 |
| April 01, 2024 | 14.17 |
| March 28, 2024 | 14.84 |
| March 27, 2024 | 15.18 |
| March 26, 2024 | 15.00 |
| March 25, 2024 | 15.35 |
| March 22, 2024 | 15.48 |
| March 21, 2024 | 16.55 |
| March 20, 2024 | 16.15 |
| March 19, 2024 | 15.82 |
| March 18, 2024 | 15.40 |
| March 15, 2024 | 15.43 |
| March 14, 2024 | 15.10 |
| March 13, 2024 | 15.64 |
| March 12, 2024 | 15.15 |
| March 11, 2024 | 15.87 |
| Date | Value |
|---|---|
| March 08, 2024 | 16.28 |
| March 07, 2024 | 16.91 |
| March 06, 2024 | 17.66 |
| March 05, 2024 | 13.79 |
| March 04, 2024 | 13.73 |
| March 01, 2024 | 13.56 |
| February 29, 2024 | 12.69 |
| February 28, 2024 | 12.55 |
| February 27, 2024 | 12.49 |
| February 26, 2024 | 12.49 |
| February 23, 2024 | 12.44 |
| February 22, 2024 | 12.24 |
| February 21, 2024 | 9.487 |
| February 20, 2024 | 9.487 |
| February 16, 2024 | 9.562 |
| February 15, 2024 | 8.654 |
| February 14, 2024 | 8.149 |
| February 13, 2024 | 7.090 |
| February 12, 2024 | 7.418 |
| February 09, 2024 | 7.165 |
| February 08, 2024 | 6.345 |
| February 07, 2024 | 6.308 |
| February 06, 2024 | 6.358 |
| February 05, 2024 | 6.244 |
| February 02, 2024 | 6.535 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.896
Minimum
May 12 2022
132.44
Maximum
Jun 30 2023
24.95
Average
12.62
Median
Price to Book Value Benchmarks
| Assertio Holdings Inc | 0.5506 |
| CytomX Therapeutics Inc | -- |
| Regeneron Pharmaceuticals Inc | 3.779 |
| Cormedix Inc | 4.237 |
| Verastem Inc | 4.823 |
Price to Book Value Related Metrics
| PS Ratio | 11.05 |
| PEG Ratio | -0.2771 |
| Price | 7.81 |
| Earnings Yield | -16.01% |
| Market Cap | 1.161B |
| PEGY Ratio | -0.2771 |